摘要 |
<p>Pharmaceutical preparations containing 1 to 10 % by weight L-lysine salt of the 2-((3-chloro-2-methylphenyl)amino]-3-pyridine carboxylic acid as active substance, 2 to 15 % by weight pharmaceutically acceptable emulsifiers, 2 to 20 % by weight pharmaceutically acceptable emollients, 0.01 to 0.2 % by weight pharmaceutically acceptable preservation substances and the remainder water made up to 100 % by weight, and possibly 0.2 to 5 % by weight rubefacients, the water being correspondingly adjusted to a total of 100 % by weight, are suitable for topical application to relieve/alleviate pain and/or inflammation in humans and animals.</p> |